Table 3.
Factors associated with timely outpatient rheumatology follow-up
| Adjusted RR | [95% CI] | p-value | |
|---|---|---|---|
| Month of follow-up | 0.99 | [0.98, 1.00] | 0.02 |
| MOC activity period | 1.10 | [0.94, 1.29] | 0.24 |
| Age at baseline visit (years) | 0.96 | [0.93, 0.99] | 0.01 |
| Male sex | 0.93 | [0.74, 1.17] | 0.55 |
| Race and ethnicity | |||
| Asian alone or in combination | 1.07 | [0.81, 1.41] | 0.64 |
| Black alone or in combination | 1.21 | [0.91, 1.61] | 0.20 |
| Hispanic White/Other | 1.34 | [1.04, 1.72] | 0.02 |
| Other/Unknown race, Non-Hispanic | 0.63 | [0.36, 1.12] | 0.12 |
| White, Non-Hispanic (reference) | - | ||
| Social Vulnerability Index | |||
| Lowest (reference) | - | ||
| Medium low | 1.07 | [0.81, 1.42] | 0.64 |
| Medium high | 0.95 | [0.69, 1.29] | 0.73 |
| Highest | 1.06 | [0.81, 1.38] | 0.67 |
| Insurance | |||
| Medicaid | 1.06 | [0.87, 1.28] | 0.58 |
| Self-Pay/Uninsured | 1.10 | [0.88, 1.38] | 0.41 |
| History of nephritis | 1.14 | [0.97, 1.33] | 0.11 |
| History of neurologic manifestations | 1.03 | [0.76, 1.38] | 0.87 |
| Recent diagnosis (<6 months)* | 1.29 | [1.09, 1.54] | 0.00 |
| Current prednisone use* | 1.18 | [1.01, 1.39] | 0.04 |
Estimates from modified robust Poisson models with subject-level random effects (N=107 SLE/MCTD patients; 683/730 visits with complete data).
*
Time-varying covariate